Report #2871623

Received Nov 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 5 yrs
State: NY
Recovered: Unknown
Vaccinated: Oct 20, 2025
Onset: Oct 20, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTAPIPV	DTAP + IPV (KINRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	42Y93	—

Symptoms (1)

Extra dose administered

Symptom narrative

extra dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 5-year-old female patient who received DTPa-IPV (Kinrix) (batch number 42Y93, expiry date 05-JUN-2026) for prophylaxis. Previously administered products included Kinrix (vaccine received on an unknown date). On 20-OCT-2025, the patient received Kinrix. On 20-OCT-2025, an unknown time after receiving Kinrix, the patient experienced extra dose administered (Verbatim: extra dose). The outcome of the extra dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 20-OCT-2025 A nurse practitioner reported that a 5-year-old patient received an extra dose of Kinrix. The nurse asked for recommendations on this situation.